SK7592002A3 - Method and compositions for treating pulmonary diseases - Google Patents

Method and compositions for treating pulmonary diseases Download PDF

Info

Publication number
SK7592002A3
SK7592002A3 SK759-2002A SK7592002A SK7592002A3 SK 7592002 A3 SK7592002 A3 SK 7592002A3 SK 7592002 A SK7592002 A SK 7592002A SK 7592002 A3 SK7592002 A3 SK 7592002A3
Authority
SK
Slovakia
Prior art keywords
pde4
rolipram
compounds
asthma
dose
Prior art date
Application number
SK759-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of SK7592002A3 publication Critical patent/SK7592002A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK759-2002A 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases SK7592002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
SK7592002A3 true SK7592002A3 (en) 2002-11-06

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
SK759-2002A SK7592002A3 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Country Status (29)

Country Link
EP (1) EP1225866A4 (pt)
JP (1) JP2003513028A (pt)
KR (1) KR20020057988A (pt)
CN (1) CN1387404A (pt)
AP (1) AP2002002496A0 (pt)
AR (1) AR029189A1 (pt)
AU (1) AU1357501A (pt)
BG (1) BG106748A (pt)
BR (1) BR0015270A (pt)
CA (1) CA2388333A1 (pt)
CO (1) CO5261512A1 (pt)
CZ (1) CZ20021512A3 (pt)
DZ (1) DZ3225A1 (pt)
EA (1) EA200200518A1 (pt)
EC (1) ECSP003747A (pt)
HK (1) HK1049107A1 (pt)
HU (1) HUP0203152A3 (pt)
IL (1) IL149367A0 (pt)
MA (1) MA26841A1 (pt)
MX (1) MXPA02004350A (pt)
NO (1) NO20022057L (pt)
OA (1) OA12076A (pt)
PE (1) PE20011005A1 (pt)
PL (1) PL355261A1 (pt)
SK (1) SK7592002A3 (pt)
TR (1) TR200201211T2 (pt)
TW (1) TWI242431B (pt)
WO (1) WO2001032127A2 (pt)
ZA (1) ZA200203435B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04002562A (es) * 2001-09-19 2004-05-31 Altana Pharma Ag Combinacion de un pde-4 y nsaid.
WO2003037349A1 (en) * 2001-10-31 2003-05-08 Merck Patent Gmbh Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
JPWO2004087149A1 (ja) * 2003-03-31 2006-06-29 協和醗酵工業株式会社 医薬組成物
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20070287689A1 (en) * 2004-10-13 2007-12-13 Kyowa Hakko Kogyo Co., Ltd. Therapeutic And/Or Preventive Agents For Chronic Skin Diseases
JP2009512677A (ja) * 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ホスホジエステラーゼタイプｉｖ阻害剤の組成物
EP3431128A1 (en) 2010-01-05 2019-01-23 MicroDose Therapeutx, Inc. Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710109B1 (en) * 1993-06-18 2004-09-15 Smithkline Beecham Corporation Method for identifying a PDE IV inhibitor
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
HK1049107A1 (zh) 2003-05-02
HUP0203152A3 (en) 2004-06-28
BG106748A (en) 2003-02-28
EA200200518A1 (ru) 2002-10-31
ZA200203435B (en) 2003-06-25
DZ3225A1 (fr) 2001-05-10
KR20020057988A (ko) 2002-07-12
AR029189A1 (es) 2003-06-18
ECSP003747A (es) 2002-05-23
AP2002002496A0 (en) 2002-06-30
WO2001032127A3 (en) 2001-12-06
PL355261A1 (en) 2004-04-05
CN1387404A (zh) 2002-12-25
TWI242431B (en) 2005-11-01
EP1225866A2 (en) 2002-07-31
OA12076A (en) 2006-05-04
PE20011005A1 (es) 2001-09-28
HUP0203152A2 (hu) 2003-01-28
CZ20021512A3 (cs) 2003-04-16
JP2003513028A (ja) 2003-04-08
CO5261512A1 (es) 2003-03-31
NO20022057D0 (no) 2002-04-30
BR0015270A (pt) 2002-06-18
IL149367A0 (en) 2002-11-10
EP1225866A4 (en) 2004-04-21
MXPA02004350A (es) 2002-11-07
CA2388333A1 (en) 2001-05-10
NO20022057L (no) 2002-06-27
MA26841A1 (fr) 2004-12-20
WO2001032127A2 (en) 2001-05-10
TR200201211T2 (tr) 2002-08-21
AU1357501A (en) 2001-05-14

Similar Documents

Publication Publication Date Title
US20050070514A1 (en) Therapies for treating respiratory diseases
EP2156840B1 (en) Use of mometasone furoate for treating airway passage and lung diseases
KR20050104367A (ko) 타 활성제와 결합하여 장기 효능을 지속하는 베타2-동근으로 구성되는 약물
US20060069155A1 (en) Method for reducing exacerbations associated with COPD
US20040176419A1 (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases
SK7592002A3 (en) Method and compositions for treating pulmonary diseases
AU2001279023B2 (en) Method for reducing exacerbations associated with COPD
JP2005508963A (ja) 喘息を治療するためのサルメテロールとフルチカゾンプロピオネートを含む医薬の組み合せ
US20060035877A1 (en) Method and compositions for treating pulmonary diseases
JP2004507494A (ja) サルメテロールとプロピオン酸フルチカゾンとの合剤の使用
AU2003292120B2 (en) New synergistic combination comprising roflumilast and formoterol
TWI494108B (zh) 糖皮質激素用以製備嚴重夜間氣喘用之於延遲釋放型的藥物之用途
AU2003288169B2 (en) Synergistic combination comprising roflumilast and (R,R) -formoterol
AU2004205324A1 (en) Method and compositions for treating pulmonary diseases
EP1261331A1 (en) Method and compositions for treating fibrotic diseases
US20030018071A1 (en) Method and compositions for treating fibrotic diseases
AU2002310620A1 (en) Composition comprising a PDE-4 inhibitor and H1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment respiratory diseases
MXPA01001994A (en) Therapies for treating pulmonary diseases